Department of Pharmaceutics, National, Centre for Pharmaceutical Nanotechnology, Institute of Pharmaceutical Education & Research (NIPER), Sector 67, S.A.S. Nagar (Mohali) Punjab, 160062, India.
Nanomedicine (Lond). 2018 Jun;13(12):1481-1493. doi: 10.2217/nnm-2018-0002. Epub 2018 Jul 4.
Current study investigates therapeutic efficacy and tolerability of benzoyl peroxide (BPO)- and adapalene (AD)-loaded modified liposomal gel (BPO-AD-mLipo gel) for improved acne therapy.
MATERIALS & METHOD: BPO-AD-mLipo were optimized and loaded in Carbopol gel. Both BPO-AD-mLipo and BPO-AD-mLipo-gel were extensively characterized for different quality attributes. Ex vivo dermal bioavailability, dermal distribution, in vivo anti-acne efficacy and skin irritation studies were performed and compared with marketed formulation (Epiduo, Galderma Laboratories LP, TX, USA).
BPO-AD-mLipo illustrated size 256.4 ± 9.3 nm with polydispersity index ∼ 0.2. Significantly enhanced dermal bioavailability (AD-2.1, 5.4; BPO-3.0, 7.83-fold) and reduction in skin irritation and papule density in animal model were observed with BPO-AD-mLipo-gel as compared with free drugs and Epiduo, respectively.
BPO-AD-mLipo gel provides effective and safer alternative approach for codelivery of anti-acne drugs.
本研究旨在考察载过氧化苯甲酰(BPO)和阿达帕林(AD)的改良脂质体凝胶(BPO-AD-mLipo 凝胶)的治疗效果和耐受性,以改善痤疮治疗效果。
对 BPO-AD-mLipo 进行优化并载入卡波姆凝胶中。对 BPO-AD-mLipo 和 BPO-AD-mLipo-凝胶进行了广泛的质量属性表征。并进行了体外皮肤生物利用度、皮肤分布、体内抗痤疮功效和皮肤刺激性研究,并与市售制剂(Epiduo,Galderma Laboratories LP,TX,USA)进行了比较。
BPO-AD-mLipo 的粒径为 256.4±9.3nm,多分散指数约为 0.2。与游离药物和 Epiduo 相比,BPO-AD-mLipo-凝胶显著提高了 AD 的皮肤生物利用度(增加 2.1、5.4 倍),降低了皮肤刺激性和丘疹密度。
BPO-AD-mLipo 凝胶为载药治疗痤疮提供了一种更有效、更安全的方法。